JLHL vs ULBI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JLHL presents a dichotomy between explosive growth and poor technical momentum. The company maintains a stable financial profile with a Piotroski F-Score of 5/9 and an exceptionally low Debt/Equity ratio of 0.15, though the absence of an Altman Z-Score limits bankruptcy risk assessment. While the Graham Number ($1.42) indicates severe overvaluation by defensive standards, the growth-based Intrinsic Value ($5.61) suggests the current price of $6.00 is nearly fair. High ROE (59.99%) and revenue growth (85.4%) are currently offset by a bearish technical trend and weak insider sentiment.
ULBI presents a contradictory profile: a stable Piotroski F-Score of 6/9 and strong liquidity are offset by deteriorating profitability and severe earnings misses. While the stock trades attractively on a Price-to-Book (0.99) and Price-to-Sales (0.68) basis, the negative profit margins and a high PEG ratio (3.81) suggest that the recent price surge is disconnected from fundamental earnings growth. The company's stability is anchored by a low Debt/Equity ratio (0.41), but high customer concentration and consistent EPS underperformance create significant risk.
Compare Another Pair
Related Comparisons
JLHL vs ULBI: Head-to-Head Comparison
This page compares Julong Holding Limited (JLHL) and Ultralife Corporation (ULBI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.